Observation of Outcomes and Side Effects of Cesium-131 in Combination With External Beam Radiation for the Treatment of Intermediate to High Risk Prostate Cancer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2007-02-28

Study Completion Date

2007-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to observe PSA response and incidence of side effects in patients diagnosed with intermediate to high risk prostate cancer and treated with Cesium-131 in combination of external beam therapy.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prospective Evaluation of Focal Brachytherapy Using Cesium-131 For Patients With Low Risk Prostate Cancer

NCT02290366

Prostate Cancer

WITHDRAWN NA

Hypofractionated Image Guided Proton Therapy for Low andIntermediate Risk Prostate Cancer

NCT02040610

Prostate Cancer

RECRUITING NA

Radiation Therapy in Combination With Brachytherapy for Clinically Localized, Intermediate Risk Prostate Cancer

NCT02280356

Prostate Cancer

COMPLETED PHASE2

High Dose-Rate Brachytherapy and/or Intensity Modulated External Beam Radiation Therapy for Prostate Cancer

NCT00243321

Adenocarcinoma of the Prostate

COMPLETED NA

Assessing the Potential for Reduced Toxicity Using Focal Brachytherapy in Early Stage, Low Volume Prostate Cancer

NCT01354951

Prostate Cancer

TERMINATED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prostate Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Histologically confirmed adenocarcinoma of the prostate
* Clinical stage T1c - T2c (AJCC 6th Edition), NX/N0, M0
* Karnofsky Performance Score of 90 to 100
* Greater than or equal to 18 years of age
* Prostate volumes by TRUS ≤ 60 cc
* I-PSS score \< 15 (alpha blockers allowed)
* Signed study-specific informed consent form prior to study entry

Intermediate Risk prostate cancer as determined by the following:

* Gleason sum of 7; PSA less than 10.1 ng/ml; Stage T2a or less
* Gleason sum 6 or less; PSA \>10.0 and \< 20.1ng/ml; Stage T2a or less
* Gleason sum 6 or less; PSA \< 10.1; Stage T2b

High risk prostate cancer as determined by the following:

* Any Gleason Sum; PSA greater than 20 ng/ml; Stage T2c or less
* Gleason Sum \> 7; Any PSA; Stage T2c or less
* Any Gleason Sum; Any PSA; Stage T2c
* Any two or three intermediate risk factor

Exclusion Criteria

* Lymph node involvement (N1)
* Evidence of distant metastases (M1)
* Any hormonal blockade or therapy that:

* Has persisted for more than 6 months by time of protocol screening; OR
* Is ongoing within 3 months of study enrollment
* Radical surgery for carcinoma of the prostate
* Prior pelvic radiation
* Previous or concurrent cancers other than basal, in situ, or squamous cell skin cancers unless disease-free for ≥ 5 years
* Major medical or psychiatric illness, which in the investigator's opinion, would prevent completion of treatment and would interfere with follow-up
* Hip prosthesis
* Inability or refusal to provide informed consent

Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes